CELLada Biotechnology
ABOUT US
Beijing CELLada Biotechnology Co., Ltd.
CELLada is a cutting-edge bio-based company focusing on organoid technology. The company has built a complete organoid industrial chain with an organoid culture system for organs and tissues such as lungs, pancreas, islet, intestine, bile duct, liver, etc. With a high-throughput tumor organoid drug screening platform for scientific research and clinical precision treatment, CELLada is committed to R&D and production of various organoids, customized organoid chips, kits, precision medicine, regenerative medicine, new drugs and smart cell culture, and also provides a variety of in vitro CRO services. The company boasts high-caliber managerial and scientific research teams, and regards promoting the development of regenerative medicine as its mission while striving to make contributions to human health.
Technology Service Platforms
service
Organoid Technology
Organoid Technology
Organoid is a three-dimensional construct composed of multiple cell types that originates from stem cells through self-organization and can simulate the architecture and functionality of native organs. As cutting-edge in vitro models, organoids have great
Organoid-on-a-chip
Organoid-on-a-chip
Organoid-on-a-chip, created through the combination of organoid technology and organ-on-a-chip technology, has integrated the advantages of both technologies, and become a more predictive preclinical experimental model that is widely used in the developme
Product Information
PRODUCTS
Organoid Workstation

At present, the development of organoid technology is still in its infancy. The main pain point hindering its industrial application is that it is difficult to be standardized. Intelligent automation is the best form of standardization. We combine biological capabilities with automation and artificial intelligence to address the bottlenecks in biomedical R&D in terms of labor-intensiveness, experimental stability and repeatability.

The Organoid Workstation centered on cell biology has realized the complete automation of common cell operations, involving steps such as cell passaging, medium change, and culture, and can automatically collect cell phenotypes and perform AI-based intelligent analysis. It can be widely used in research mainly studying cells.

Organoid Workstation
Metabolomics Sample Preparation Workstation

Manual sample preparation for metabolomics research causes many variables, such as large differences that could occurs between batches and users. Automated sample preparation helps improve sample throughput, consistency, and reproducibility, thereby reducing the need for repetitive assays. The workstation starts metabolomics research with a simple, reliable, standardized, and automated sample preparation workflow.

Metabolomics Sample Preparation Workstation
Flow Cytometry Sample Preparation Workstation
It mainly ensures the simplification of cell separation of samples (blood, tissue, cell mass), and ensures the establishment of a continuous and efficient automated process through the close combination of automated instruments and reagents. The workstation can meet the requirements for high-throughput extraction of single cell populations or cells of the same size, and perform automated cell culture in different plates. With a continuous automated processing flow, the workstation avoids the influence on cell viability caused by long-term storage, and the contamination that is easy to occur during the current operation process.
Flow Cytometry Sample Preparation Workstation
News Center
news
干细胞备案项目增至111个,国内临床研究备案项目汇总!
2022年01月22日
干细胞备案项目增至111个,国内临床研究备案项目汇总!
2022年1月22日/医麦客新闻 eMedClub News/--干细胞技术一直以来被视为再生医学技术,被誉为继药物治疗和手术治疗之后的第三次医学革命,是近年来国际医学前沿重点发展领域。
Science子刊:实体瘤的屏障找到了!CAR-T疗法将如何“破冰”?丨医麦黑科技
2022年01月22日
Science子刊:实体瘤的屏障找到了!CAR-T疗法将如何“破冰”?丨医麦黑科技
2022年1月22日/医麦客新闻 eMedClub News/--近年来,全球已有多款CAR-T产品获批上市,用于治疗不同类型的血液系统恶性肿瘤。CAR-T在血液瘤领域一路高歌猛进,而在患者人群占比超90%以上的实体瘤领域,CAR-T疗法则进展缓慢,困难重重。
​类器官:组织培养、科学研究与药物筛选
2022年01月13日
​类器官:组织培养、科学研究与药物筛选
提起类器官,大家的第一反应也许是这样的:在培养皿中,一个小小的器官悄然生长着……类器官(Organoid)是在体外用3D培养技术对干/祖细胞进行诱导分化形成的在结构和功能上都类似目标器官/组织的三维细胞复合体。类器官其具有稳定的表型和遗传学特征,能够在体外长期培养。
Copyright © Beijing CELLada Biotechnology Co., Ltd.· All rights reserved
Technical Support:Web design